abrdn Life Sciences Investors Share Price Today: Live Updates & Key Insights
abrdn Life Sciences Investors share price today is $16.19, up -0.55%. The stock opened at $16.25 against the previous close of $16.28, with an intraday high of $16.33 and low of $16.15.
abrdn Life Sciences Investors Share Price Chart
abrdn Life Sciences Investors
abrdn Life Sciences Investors Share Price Performance
abrdn Life Sciences Investors Institutional Holdings
abrdn Life Sciences Investors Market Status
abrdn Life Sciences Investors Fundamentals
Market Cap 479.20 M
PB Ratio 0.9381
PE Ratio 5.8029
Enterprise Value 479.13 M
Total Assets 515.38 M
Volume 138100
abrdn Life Sciences Investors Company Financials
About abrdn Life Sciences Investors & investment objective
Company Information Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Organisation Asset Management
Employees 0
Industry Asset Management
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
abrdn Life Sciences Investors FAQs
What is the share price of abrdn Life Sciences Investors today?
The current share price of abrdn Life Sciences Investors is $16.19.
Can I buy abrdn Life Sciences Investors shares in India?
Yes, Indian investors can buy abrdn Life Sciences Investors shares by opening an international trading and demat account with Motilal Oswal.
How to buy abrdn Life Sciences Investors shares in India?
You can easily invest in abrdn Life Sciences Investors shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy abrdn Life Sciences Investors shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of abrdn Life Sciences Investors.
Can I buy fractional shares of abrdn Life Sciences Investors?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of abrdn Life Sciences Investors?
abrdn Life Sciences Investors has a market cap of $479.20 M.
In which sector does abrdn Life Sciences Investors belong?
abrdn Life Sciences Investors operates in the Asset Management sector.
What documents are required to invest in abrdn Life Sciences Investors stocks?
To invest, you typically need:
What is the PE and PB ratio of abrdn Life Sciences Investors?
The PE ratio of abrdn Life Sciences Investors is 5.80 and the PB ratio is 0.94.